PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
83 hedge funds and large institutions have $330M invested in POINT Biopharma Global Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 33 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 17 closing their positions.
Holders
83
Holders Change
+16
Holders Change %
+23.88%
% of All Funds
1.4%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
33
Increased
26
Reduced
12
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
BlackRock
New York
|
$41.8M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$15.1M |
| 3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$13.3M |
| 4 |
4
Geode Capital Management
Boston,
Massachusetts
|
$9.05M |
| 5 |
5
Northern Trust
Chicago,
Illinois
|
$4.39M |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
101
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 28 | +28 | New |
|